Farringdon Capital’s Encompass Health EHC Stock Holding History

Farringdon Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,400	Closed	-$619K	–	265
2026 Q1	$619K	Buy	+6,400	New	+$656K	0.14%	202

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Farringdon Capital's EHC Position: Q2 2026 in Review

Farringdon Capital sold out of Encompass Health (EHC) in Q2 2026, closing a stake of 6,400 shares — an estimated $619K sold.

Farringdon Capital first reported a position in EHC in Q1 2026 and held it in 1 quarter. The position peaked at $619K in Q1 2026. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

Farringdon Capital reported no remaining Encompass Health position as of Q2 2026 after selling out during the quarter.
Farringdon Capital sold 6,400 Encompass Health shares in Q2 2026, an estimated $619K.
Farringdon Capital first reported a position in Encompass Health in Q1 2026 and held it in 1 quarter.
Farringdon Capital's Encompass Health position peaked at $619K in Q1 2026.
599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.